Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Identification of regulators of
Toxoplasma gondii
bradyzoite development and cyst formation is the most direct way to address the importance of parasite development in long-term persistence and reactivation of this parasite. Here we show that a
T. gondii
gene (named
Regulator of Cystogenesis 1
;
ROCY1
) is sufficient for
T. gondii
bradyzoite formation in vitro and in vivo.
ROCY1
encodes an RNA binding protein that has a preference for 3’ regulatory regions of hundreds of
T. gondii
transcripts, and its RNA-binding domains are required to mediate bradyzoite development. Female mice infected with Δ
ROCY1
parasites have reduced (>90%) cyst burden. While viable parasites can be cultivated from brain tissue for up to 6 months post-infection, chronic brain-resident Δ
ROCY1
parasites have reduced oral infectivity compared to wild type. Despite clear defects in bradyzoite formation and oral infectivity, Δ
ROCY1
parasites were able to reactivate with similar timing and magnitude as wild type parasites for up to 5 months post-infection. Therefore while
ROCY1
is a critical regulator of the bradyzoite developmental pathway, it is not required for parasite reactivation, raising new questions about the persisting life stage responsible for causing recrudescent disease.
Toxoplasma gondii
can develop into dormant bradyzoites that persist in tissue and can be reactivated. Here the authors identify an RNA binding protein that they call Regulator of Cystogenesis 1 (ROCY1), and show that it is required for bradyzoite development in vitro and in vivo but is not required for long term persistence of parasites that reactivate in a mouse model of recrudescence.